Literature DB >> 11558649

A dynamic programming approach to the efficient design of clinical trials.

K Claxton1, K M Thompson.   

Abstract

If the prospective evaluation of all feasible strategies of patient management is not possible or efficient then this poses a number of questions: (i) which clinical decision problems will be worth evaluating through prospective clinical research; (ii) if a clinical decision problem is worth evaluating which of the many competing alternatives should be considered "relevant" and be compared in the evaluation; (iii) what is the optimal (technically efficient) scale of this prospective research; (iv) what is an optimal allocation of trial entrants between the competing alternatives; and (v) what is the value of this proposed research? The purpose of this paper is to present a Bayesian decision theoretic approach to the value of information which can provide answers to each of these questions. An analysis of the value of sample information was combined with dynamic programming and applied to numerical examples of sequential decision problems. The analysis demonstrates that this approach can be used to establish: optimal sample size; optimal sample allocation; and the societal payoff to proposed research. This approach provides a consistent way to identify which of the competing alternatives can be regarded as "relevant" and should be included in any evaluative study design. Bayesian decision theory can provide a general methodological framework that can ensure consistency in decision making between service provision, research and development, and the design, conduct and interpretation clinical research.

Entities:  

Mesh:

Year:  2001        PMID: 11558649     DOI: 10.1016/s0167-6296(01)00093-5

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  9 in total

Review 1.  Sample size determination for cost-effectiveness trials.

Authors:  Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 2.  Role of pharmacoeconomic analysis in R&D decision making: when, where, how?

Authors:  Paul Miller
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts.

Authors:  Mohan V Bala; Josephine A Mauskopf
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Value of information and pricing new healthcare interventions.

Authors:  Andrew R Willan; Simon Eckermann
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

Review 5.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

Review 6.  Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research).

Authors:  Bernard Thébaud; Manoj Lalu; Laurent Renesme; Sasha van Katwyk; Justin Presseau; Kednapa Thavorn; Kelly D Cobey; Brian Hutton; David Moher; Roger F Soll; Dean Fergusson
Journal:  Stem Cells Transl Med       Date:  2021-02-11       Impact factor: 6.940

7.  Study protocol: differential effects of diet and physical activity based interventions in pregnancy on maternal and fetal outcomes--individual patient data (IPD) meta-analysis and health economic evaluation.

Authors:  Anneloes E Ruifrok; Ewelina Rogozinska; Mireille N M van Poppel; Girish Rayanagoudar; Sally Kerry; Christianne J M de Groot; SeonAe Yeo; Emma Molyneaux; Fionnuala M McAuliffe; Lucilla Poston; Tracy Roberts; Richard D Riley; Arri Coomarasamy; Khalid Khan; Ben Willem Mol; Shakila Thangaratinam
Journal:  Syst Rev       Date:  2014-11-04

Review 8.  Decision-theoretic designs for small trials and pilot studies: A review.

Authors:  Siew Wan Hee; Thomas Hamborg; Simon Day; Jason Madan; Frank Miller; Martin Posch; Sarah Zohar; Nigel Stallard
Journal:  Stat Methods Med Res       Date:  2015-06-05       Impact factor: 3.021

9.  Combining Model-Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial Design.

Authors:  Daniel Hill-McManus; Dyfrig A Hughes
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.